ban-icon

From Strength to Strength

Growing steadily in scale and reach

2024
  • Nirma Limited acquired majority stake in Glenmark Life Sciences
  • Company name changed to Alivus Life Sciences
2024
2022
  • Dahej Manufacturing facility gets ANVISA GMP certified
2022
2021
  • Achieved milestone of 403 cumulative drug master files (DMFs) across multiple markets globally
  • Gets listed on Indian Stock Exchanges
2021
2019
  • The API business was spun off into Glenmark Life Sciences
  • Ankleshwar plant inspected by US FDA, Health Canada and PMDA, Japan
2019
2018
  • Dahej plant inspected by EDQM, ANSM and US FDA*
  • Mohol plant inspected by US FDA*

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2018
2016
  • Dahej plant inspected by PMDA Japan

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2016
2015
  • Dahej plant inspected by US FDA

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2015
2013
  • Commenced manufacturing at Dahej, Gujarat*
  • Ankleshwar plant inspected by COFEPRIS*

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2013
2012
  • Ankleshwar plant inspected by PMDA and AFSSAPS

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2012
2008
  • Ankleshwar plant at Gujarat inspected by US FDA*

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2008
2004
  • Commenced manufacturing at Mohol, Maharashtra*

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2004
2003
  • First product registered with US FDA*
  • Acquired Glaxo SmithKline’s (GSK) API manufacturing plant in Ankleshwar, Gujarat *

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2003
2002
  • Established manufacturing plant at Kurkumbh, Maharashtra*

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2002
2001
  • Glenmark Pharmaceuticals established its API business *

*Prior to the API business being transferred to Glenmark Life Sciences pursuant to the Business Purchase Agreement.

2001
world

Understand how we comply with the requirements of regulatory agencies around the world